Switzerland-listed chocolate maker Nestlé has made a corporate venturing investment of undisclosed size in Accera, which provides milkshakes for people with Alzheimer’s disease.
Luis Cantarell, president and chief executive of Nestlé Health Science, a subsidiary set up by the Swiss company last year, said: “The significance of this is not the [undisclosed] size of the investment, but the fact that it is our first step in developing our brain health portfolio.”
In December 2010, Accera, which also makes drugs for…
